Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma

Podobne zapisy

• Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
  od: Pointer, David T., i wsp.
  Wydane: (2020)
• Neoadjuvant GTX Chemotherapy and IMRT-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
  od: Patel, Manish, i wsp.
  Wydane: (2011)
• TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma
  od: Glazer, Evan S., i wsp.
  Wydane: (2016)
• Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer
  od: Mellon, Eric A., i wsp.
  Wydane: (2016)
• Increased Expression of the GLUT-1 Gene is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma
  od: Davis-Yadley, Ashley H., i wsp.
  Wydane: (2016)